nadp has been researched along with Hyperplasia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arner, A; de Sá, VP; Ekblad, E; Harnek, J; Stenram, U; Zoucas, E | 1 |
| Brady, EP; Chandar, N; Eagon, PK; Elm, MS; Kelly, RH; Rao, B; Rao, KN; Shinozuka, H | 1 |
| Pashko, LL; Schwartz, AG | 1 |
| Gaikwad, A; Gonzalez, FJ; Jaiswal, AK; Long, DJ; Montgomery, CA; Multani, A; Pathak, S | 1 |
| Altmann, FP; Bitensky, L; Chayen, J; Daly, JR | 1 |
| Charreau, EH; Dufau, ML; Villee, CA; Villee, DB | 1 |
6 other study(ies) available for nadp and Hyperplasia
| Article | Year |
|---|---|
Intimal hyperplasia in balloon dilated coronary arteries is reduced by local delivery of the NO donor, SIN-1 via a cGMP-dependent pathway.
Topics: Actins; Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Cyclic GMP; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Guanylate Cyclase; Hyperplasia; Intermediate Filaments; Molsidomine; Myosins; NAD(P)H Dehydrogenase (Quinone); NADP; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Signal Transduction; Sus scrofa; Time Factors; Tunica Intima | 2011 |
Hepatic hyperplasia and cancer in rats: metabolic alterations associated with cell growth.
Topics: Animals; Blotting, Western; Carcinogens; Cell Division; Cholesterol; Clofibrate; Diethylhexyl Phthalate; Glucosephosphate Dehydrogenase; Hydroxymethylglutaryl CoA Reductases; Hyperplasia; Liver; Liver Neoplasms, Experimental; Malate Dehydrogenase; Male; NADP; Pentose Phosphate Pathway; Pyrimidines; Rats; Rats, Inbred F344; Receptors, LDL; RNA, Messenger | 1997 |
Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Topics: Androstenes; Animals; Antineoplastic Agents; Binding, Competitive; Capillary Permeability; Carcinogens; Cations; Corticosterone; Dehydroepiandrosterone; DNA; Epidermis; Female; Free Radicals; Hyperplasia; Inflammation; Liposomes; Mice; NADP; Tetradecanoylphorbol Acetate | 2001 |
Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.
Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Differentiation; Chromosomes; DNA-Binding Proteins; Female; Genes, Tumor Suppressor; Hyperplasia; Male; Mice; Myeloproliferative Disorders; NAD(P)H Dehydrogenase (Quinone); NADP; Nuclear Proteins; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2002 |
Response of human breast-cancer tissue to steroid hormones in vitro.
Topics: Adenocarcinoma; Androstanols; Breast Diseases; Breast Neoplasms; Culture Media; Culture Techniques; Estradiol; Histocytochemistry; Humans; Hyperplasia; Lymph Nodes; Lymphatic Metastasis; NADP; Testosterone | 1970 |
Synthesis of 5-alpha-pregnane-3,20-dione by fetal and adult human adrenals.
Topics: Adrenal Glands; Adrenocortical Hyperfunction; Carbon Isotopes; Chromatography, Thin Layer; Countercurrent Distribution; Crystallization; Fetus; Humans; Hyperplasia; In Vitro Techniques; NADP; Pregnanes; Pregnenolone; Progesterone; Tritium | 1968 |